Dehydrated Alcohol Injection Market Segmentation:
By Treatment Type
- Monotherapy
- Combination Therapy
- Supportive Therapy
By End-User
- Hospitals
- Clinics
- Ambulatory Centers
- Emergency Services
- Other End Users
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of the Middle East
Frequently Asked Questions
The current (2023) market size is $186 million.
Key growth drivers include rising methanol poisoning cases, favorable treatment guidelines, improved diagnostics, greater production capacity, and launches of novel antidotes.
Low awareness in emerging markets, high costs, use of alternatives in some regions, and regulatory barriers around product approvals.
Monotherapy injections for standalone use.
Recro Pharma, Par Pharmaceutical, Vertellus Holdings, Shandong Xinhua Pharm, Linyi Sanai Pharmaceutical.
The market will grow at a 8.1% CAGR, reaching $346.8 million by 2031.
Key drivers are rising methanol poisoning cases, treatment guidelines recommending injections as first-line, improved diagnostics and production capacity, and new product launches.